Influence of Marker of Insulin Resistance Upon Hepatitis C Virus (HCV) Treatment Responses to PEG Intron and Rebetol Therapy
Clinical trial NCT00351871 · COMPLETED
Trial details
- NCT number
- NCT00351871
- Sponsor
- Louisiana State University Health Sciences Center in New Orleans
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2002-04-01
- Primary completion
- 2007-11-01
- Enrollment
- 400
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.